2018 Agenda Highlights: Why will this be the best operationally focussed oncology conference on the West Coast in 2018?

Sharing insights on how to differentiate your oncology trial in a competitive landscape attracting both physicians and patients

The competition for oncology sites, staff and patients in this region is tremendous. The high competition makes recruitment even harder than it already is. Delayed patient recruitment and study start-up has detrimental effects on study budget and timelines.

Archana Sah, Therapeutic Area Leader, Oncology, Director, Clinical Operations at Genentech, will be speaking about how to differentiate your trial in such a competitive landscape, making you stand out.

INTERACTIVE SESSION: Discussing the advantages and operational challenges associated with combination trials in oncology to improve efficiency and retention in your study

Franco Davi, Senior Clinical Program Leader at Genentech, will host an interactive session whereby the audience will come up with their biggest challenges and potential strategies for overcoming common hurdles within combination trials. This session will give you the opportunity to ask questions and come up with the 10 best practices for completing a successful combination study.

PANEL DISCUSSION: Should your clinical oncology outsourcing model be Functional, Full-Service, or Hybrid?

Sameena Sharif, Vice President of Business Operations, Portfolio Planning and Project Management at Astex Pharmaceuticals, will be moderating a discussion with 3 industry leaders debating the best oncology outsourcing models. This panel will explore the pros and cons of Hybrid vs Full-Service outsourcing strategies, to find the best model for you. As an attendee you will be able to ask the panellists probing questions and get involved with in-depth discussions.

Balancing clinical trial perspectives by involving patients in the protocol design phase of oncology trialsĀ 

Making trials more patient-centric is something all companies are working towards. By aligning objectives of patients, sponsors and physicians we are able to increase patient engagement and retention in oncology studies.

Deborah Collyar, President of Patient Advocates In Research, will be discussing strategies for working towards a patient-focussed approach to oncology trials.